Navigation Links
Chemo May Boost Survival After Lung Cancer Surgery
Date:3/24/2010

Therapy improves outcome for some patients with operable disease, review finds

WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies.

The first meta-analysis of 34 studies involving almost 8,500 patients (and more than 3,300 deaths) showed that survival at five years was 64 percent for patients who had chemotherapy and surgery, and 60 percent for patients who had surgery alone.

The second meta-analysis of 13 studies with 2,660 patients (1,909 deaths) showed that survival at five years was 33 percent for patients who had surgery plus radiotherapy and chemotherapy, and 29 percent for patients who had surgery plus radiotherapy alone.

The report was released online March 23 in advance of publication in an upcoming print issue of The Lancet.

"In both meta-analyses we noted little variation in effect according to the type of chemotherapy, other trial characteristics, or patient subgroup," wrote the British and French researchers.

According to a team led by Sarah Burdett of the Medical Research Council Clinical Trials Unit, London, adding in chemotherapy boosted outcomes whether or not patients got the treatment alongside surgery alone, or surgery plus radiotherapy. They contend that, in patients deemed suitable, "platinum-based chemotherapy should be considered for patients at high risk of recurrence -- i.e., those with stage 1B, 2 or 3 disease."

The finding supports the use of chemotherapy in patients with non-small cell lung cancer who have also undergone tumor-removing surgery, Dr. Gregory P. Kalemkerian, of the University of Michigan, wrote in an accompanying commentary.

"Although the survival benefit seems small, worldwide adoption of adjuvant chemotherapy could save up to 10,000 lives every year," he said.

More information

The U.S. National Cancer Institute has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: The Lancet, news release, March 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
2. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
3. Researchers find new chemotherapy combination shows promise in endometrial cancer
4. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
5. Are New Chemo Treatments Cost-Effective?
6. Older Colon Cancer Patients Less Likely to Get Chemo
7. Study evaluates costs and benefits of new chemotherapy drugs
8. Scientists identify microRNA as possible cause of chemotherapy resistance
9. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
10. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
11. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... In its efforts of bringing quality senior care ... franchise development and expansion as it welcomes Ferdie Vasquez of the new 1Heart Caregiver ... his 32 years of working in various industries. He had been a Franchise ...
(Date:4/28/2016)... ... 2016 , ... Sublime Beauty® is offering a special deal on its webstore. , Buy 1 ... is applied to the product with lesser value. In addition, a free bonus of ... more in products. , "So many women (men, too) love our products and get good ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ProText Layouts ... Final Cut Pro X . With ProText Layouts, video editors can create ... to match the length and scale of texts. Creating text-based videos have never ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... 2016 , ... The ARRS 2016 Annual Meeting ... from around the globe who attended a week’s worth of cutting-edge scientific presentations, ... included the introduction of the 2016 ARRS Distinguished Educator, Dr. Gerald F. Abbott, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Treato , the ... announced today that it has been named a Cool ... in Life Sciences, 2016, Stephen Davies , ... focuses on life-science- oriented analytics, algorithms and smart machine ... doctors, confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
Breaking Medicine Technology: